Information portal on various topics of management of public resources of the Portuguese State

Project sheet

Name

Assistant Researcher in Neurosciences with focus on Neurodegenerative diseases

Total project amount

85,17 thousand €

Amount paid

85,17 thousand €

Non-refundable funding

85,17 thousand €

Loan funding

0 €

Start date

16.06.2025

Expected end date

31.03.2026

Dimension

Resilience

Component

Qualifications and Skills

Investment

Science Plus Training

Operation code

02/C06-i06/2024.P2023.14718.TENURE.010

Summary

Job descriptionWe are seeking a motivated and skilled Assistant Researcher in the field of Neurosciences with a specific focus on neurodegenerative diseases and mitochondria to join to UCIBIO Mitochondria and Neurobiology Lab located at University of Porto–Faculty of Pharmacy (FFUP). The prospective employee will investigate the role of mitochondria in the aging process and neurodegenerative diseases, as well as developing new disease models and therapeutic strategies to alleviate mitochondrial dysfunction.Briefly, the prospective employee will have the following responsibilities:Write funding applications aimed at securing funding to investigate new therapeutic strategies for neurodegenerative and mitochondrial diseases.Stay current with the latest knowledge and techniques in Neurosciences and mitochondrial physiology.Develop new disease models and techniques to study mitochondrial function and neurodegeneration.Plan, conduct experiments (e.g., in vitro and in vivo assays, microscopy, molecular biology) and analyze data in order to:Investigate mitochondrial dysfunction in the aging process and neurodegenerative diseases.Test the impact of modulating mitochondrial dynamics on mitochondria remodeling in aging and in neurodegeneration.Identify new therapeutic targets to attenuate mitochondrial dysfunction and neurodegeneration.Collaborate with interdisciplinary teams to study mitochondria role on aging/ neurodegeneration.Disseminate new research findings through high-impact publications and scientific presentations.Participate in the training of young researchers by supervising undergraduate, master, and PhD students.Organize and participate in outreach activities and scientific meetings.Maintain records and participate in the laboratory management. Scientific profile:The ideal candidate should possess the following qualifications and attributes:PhD degree in Pharmaceutical Sciences or in a related field.Extensive background in Neurosciences and Mitochondria, evidenced by robust publications in these fields.Successful history of securing competitive funding as a principal investigator.Proven ability to design and implement experiments involving molecular biology and microscopy, as demonstrated by first-author publications utilizing these methodologies.Experience working with both cell culture systems and in vivo models, including proficiency in handling rodent and zebrafish models.Sound knowledge and practical experience in imaging and data analysis, including in statistical analysis.Scientific autonomy, with the ability to drive research projects, as evidenced by publications as corresponding author.Proven ability to work within interdisciplinary research teams.Strong oral communication abilities, promoting dissemination of research findings through presentations in seminars or conferences.Capacity to mentor and supervise students and other young researchers, as well as experience in teaching activities.Ability to organize scientific events.Self-motivated and proactive in promoting a collaborative and supportive work environment. RationaleThe UCIBIO mission is divided into 4 thematic lines, and the prospective employee will conduct investigations addressing 2 of them: “Biological and Biomolecular Interactions” and “Diagnostics, Drug Discovery and Development”, which aim to understand the biomolecular mechanisms crucial for cellular pathophysiology and to find innovative therapies for currently incurable diseases, respectively. The prospective employee will address mechanistically and therapeutically the involvement of mitochondria in major societal concerns: aging and neurodegenerative disorders.According to the World Health Organization, life expectancy increased by more than 6 years between 2000 and 2019, and this trend is expected to continue due to improved living conditions, raising concerns about aging-related diseases and the associated economic costs. During aging, there is a progressive accumulation of mutations in the mitochondrial DNA and a decline in mitochondrial activity, disturbing cell functioning. However, several important questions need to be answered to mechanistically clarify the connection between aging/aging-related diseases and mitochondrial homeostasis, thereby identifying strategies to target mitochondrial dysfunction. Namely, how mutations affect mitochondrial DNA structure/organization and how this impacts the aging; also, how aging affects signaling between mitochondria and other cellular compartments, and how can we promote mitochondrial health (PMID: 37118378).Regarding FFUP, it aims to combine teaching with excellence in scientific research oriented towards the needs of society, as this proposal aims to do. Moreover, research performed by the prospective employee will contribute to the advance of “Pharmacology and Pharmacy” and “Biochemistry and Molecular Biology”, which are some of main research areas of interest of FFUP.

Beneficiaries

Within the scope of the Recovery and Resilience Plan, two types of beneficiaries are responsible for carrying out the projects and using the funding provided. Due to their similar role, the reference to these two types of beneficiaries has been simplified and unified under the term "Beneficiary".
The two types are::
  • Direct Beneficiaries are those whose funding and projects to implement are part of the Recovery and Resilience Plan that has been negotiated and approved by the European Union;
  • Final Beneficiaries are those whose funding and projects to implement are approved following a selection process through Calls for Applications.

Call for applications

As part of the Call for Applications, submissions are requested to select the projects and final beneficiaries to whom funding will be awarded. Specific selection criteria are defined for each call, which must be reflected in the applications submitted and assessed.

The project is appraised on the basis of its compliance with the selection criteria laid down in the calls for applications, and a final score may be awarded, where applicable.

Final evaluation score

9,0
Important note

The components for calculating the assessment score can be found in the selection criteria document mentioned below.

Selection criteria

The funding selection criteria to which this project and its final beneficiary were subject and its score can be found in detail on the Recuperar Portugal platform.

Beneficiaries

Intermediate beneficiaries

Beneficiaries

Procurement

Beneficiaries representing public entities implement their project by signing one or more contracts with suppliers for goods or services through public procurement procedures.

To ensure and provide the utmost transparency in all these contracts, a list of the contracts that were signed under this project is available here, along with the information available on the Base.Gov platform. Please note that, according to the legislation in force at the time the contract was signed, some exceptions do not require the publication of the contracts signed on this platform, and, therefore, no information is available in such cases.

Geographic distribution

85,17 thousand €

Total amount of the project

Percentage of the amount already paid for implementing projects

, 100 %,

Where was the money spent

By county

1 county financed .

  • Porto 85,17 thousand € ,
Source EMRP
10.02.2026
All themes
Transparency without leading